“Evaluation of Interleukin – 12 and Interleukin – 23 Expressions in Patients With Active and Latent Tuberculosis Infection”. 2022. Journal of Pharmaceutical Negative Results, November, 2148-53. https://mail.pnrjournal.com/index.php/home/article/view/3436.